FDA gives emergency use authorization for Regeneron COVID-19 treatment

“Authorizing these monoclonal antibody therapies may help outpatients avoid hospitalization and alleviate the burden on our health care system,” FDA Commissioner Dr. Stephen Hahn said in a statement.

Leave a Reply

Your email address will not be published. Required fields are marked *